OTCMKTS:MEDGF Medacta Group (MEDGF) Stock Price, News & Analysis $83.91 0.00 (0.00%) (As of 05/13/2024) Add Compare Share Share Stock Analysis Stock AnalysisHeadlinesShort Interest About Medacta Group Stock (OTCMKTS:MEDGF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medacta Group alerts:Sign Up Key Stats Today's Range$83.91▼$83.9150-Day Range$83.91▼$83.9152-Week Range$83.91▼$86.33Volume11 shsAverage Volume200 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMedacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine procedures. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.Read More… “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Receive MEDGF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medacta Group and its competitors with MarketBeat's FREE daily newsletter. Email Address MEDGF Stock News HeadlinesMedacta unveils the extended enhancements to its Hip Revision PlatformOctober 21, 2024 | markets.businessinsider.comShould You Investigate Medacta Group SA (VTX:MOVE) At CHF121?October 15, 2024 | finance.yahoo.comTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…November 21, 2024 | Colonial Metals (Ad)Medacta Hosts Inaugural Capital Markets Day, Showcasing Responsible Innovation and Effective Growth StrategySeptember 30, 2024 | markets.businessinsider.comMedacta Group SA: Buy Rating Affirmed Amid Strong Growth Strategy and Market Expansion PotentialSeptember 27, 2024 | markets.businessinsider.comMedacta Group SA (VTX:MOVE) insiders have significant skin in the game with 70% ownershipSeptember 26, 2024 | finance.yahoo.comMighty Oak Medical and Medacta Announce Non-Exclusive Worldwide License of Patents for Patient-Specific Pedicle Screw GuidesAugust 29, 2024 | markets.businessinsider.comTHINK Surgical Receives FDA 510(k) Clearance for Medacta GMK Sphere® and SpheriKA® implants on TMINI® Miniature Robotic SystemAugust 29, 2024 | tmcnet.comSee More Headlines MEDGF Stock Analysis - Frequently Asked Questions How have MEDGF shares performed this year? Medacta Group's stock was trading at $83.91 at the beginning of 2024. Since then, MEDGF stock has increased by 0.0% and is now trading at $83.91. View the best growth stocks for 2024 here. How do I buy shares of Medacta Group? Shares of MEDGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:MEDGF CUSIPN/A CIKN/A Webwww.medacta.com Phone41 91 696 60 60FaxN/AEmployees1,826Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (OTCMKTS:MEDGF) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medacta Group SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Medacta Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
